Exact Sciences
EXAS
#1543
Rank
โ‚น934.06 B
Marketcap
โ‚น5,047
Share price
5.86%
Change (1 day)
-17.45%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น234.36 Billion

According to Exact Sciences's latest financial reports the company's total debt is โ‚น234.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น212.67 B5.04%
2022-12-31โ‚น202.47 B14.2%
2021-12-31โ‚น177.30 B4.02%
2020-12-31โ‚น170.44 B150.28%
2019-12-31โ‚น68.10 B41.31%
2018-12-31โ‚น48.19 B16857.84%
2017-12-31โ‚น0.28 B-23.86%
2016-12-31โ‚น0.37 B-6.63%
2015-12-31โ‚น0.39 B112.11%
2014-12-31โ‚น0.18 B-30.12%
2013-12-31โ‚น0.26 B141.01%
2012-12-31โ‚น0.11 B111.56%
2011-12-31โ‚น52.9 M18.05%
2010-12-31โ‚น44.81 M-51.42%
2009-12-31โ‚น92.24 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น12.15 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.67 B-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.98 B-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.163 T 823.03%๐Ÿ‡ซ๐Ÿ‡ท France